Lähde Marianne, Heino Sarika, Högström Jenny, Kaijalainen Seppo, Anisimov Andrey, Flanagan Dustin, Kallio Pauliina, Leppänen Veli-Matti, Ristimäki Ari, Ritvos Olli, Wu Katherine, Tammela Tuomas, Hodder Michael, Sansom Owen J, Alitalo Kari
Translational Cancer Medicine Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Translational Cancer Medicine Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, University of Helsinki and Helsinki University Hospital, Helsinki, Finland; Cancer Research Institute, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
Gastroenterology. 2021 Jan;160(1):245-259. doi: 10.1053/j.gastro.2020.09.011. Epub 2020 Sep 14.
BACKGROUND & AIMS: Mutations in the APC gene and other genes in the Wnt signaling pathway contribute to development of colorectal carcinomas. R-spondins (RSPOs) are secreted proteins that amplify Wnt signaling in intestinal stem cells. Alterations in RSPO genes have been identified in human colorectal tumors. We studied the effects of RSPO1 overexpression in Apc mutant mice.
An adeno associated viral vector encoding RSPO1-Fc fusion protein, or control vector, was injected into Apcmice. Their intestinal crypts were isolated and cultured as organoids. which were incubated with or without RSPO1-Fc and an inhibitor of transforming growth factor beta receptor (TGFBR). Livers were collected from mice and analyzed by immunohistochemistry. Organoids and adenomas were analyzed by quantitative reverse-transcription PCR, single cell RNA sequencing, and immunohistochemistry.
Intestines from Apc mice injected with the vector encoding RSPO1-Fc had significantly deeper crypts, longer villi, with increased EdU labeling, indicating increased proliferation of epithelial cells, in comparison to mice given control vector. AAV-RSPO1-Fc-transduced Apc mice also developed fewer and smaller intestinal tumors and had significantly longer survival times. Adenomas of Apc mice injected with the RSPO1-Fc vector showed a rapid increase in apoptosis and in the expression of Wnt target genes, followed by reduced expression of messenger RNAs and proteins regulated by the Wnt pathway, reduced cell proliferation, and less crypt branching than adenomas of mice given the control vector. Addition of RSPO1 reduced the number of adenoma organoids derived from Apc mice and suppressed expression of Wnt target genes but increased phosphorylation of SMAD2 and transcription of genes regulated by SMAD. Inhibition of TGFBR signaling in organoids stimulated with RSPO1-Fc restored organoid formation and expression of genes regulated by Wnt. The TGFBR inhibitor restored apoptosis in adenomas from Apc mice expressing RSPO1-Fc back to the same level as in the adenomas from mice given the control vector.
Expression of RSPO1 in Apc mice increases apoptosis and reduces proliferation and Wnt signaling in adenoma cells, resulting in development of fewer and smaller intestinal tumors and longer mouse survival. Addition of RSPO1 to organoids derived from adenomas inhibits their growth and promotes proliferation of intestinal stem cells that retain the APC protein; these effects are reversed by TGFB inhibitor. Strategies to increase the expression of RSPO1 might be developed for the treatment of intestinal adenomas.
APC基因及Wnt信号通路中其他基因的突变促成结直肠癌的发生。R-spondins(RSPOs)是在肠道干细胞中增强Wnt信号传导的分泌蛋白。人类结直肠肿瘤中已发现RSPO基因的改变。我们研究了RSPO1过表达在Apc突变小鼠中的作用。
将编码RSPO1-Fc融合蛋白的腺相关病毒载体或对照载体注射到Apc小鼠体内。分离它们的肠隐窝并培养成类器官,将其与有无RSPO1-Fc及转化生长因子β受体(TGFBR)抑制剂一起孵育。从小鼠体内收集肝脏并通过免疫组织化学进行分析。通过定量逆转录PCR、单细胞RNA测序和免疫组织化学对类器官和腺瘤进行分析。
与注射对照载体的小鼠相比,注射编码RSPO1-Fc载体的Apc小鼠的肠道隐窝更深,绒毛更长,EdU标记增加,表明上皮细胞增殖增加。AAV-RSPO1-Fc转导的Apc小鼠还形成了更少、更小的肠道肿瘤,并且存活时间显著延长。注射RSPO1-Fc载体的Apc小鼠的腺瘤显示凋亡和Wnt靶基因表达迅速增加,随后Wnt通路调节的信使RNA和蛋白质表达减少,细胞增殖减少,隐窝分支比注射对照载体的小鼠的腺瘤少。添加RSPO1减少了源自Apc小鼠的腺瘤类器官数量,并抑制了Wnt靶基因的表达,但增加了SMAD2的磷酸化和SMAD调节的基因转录。在RSPO1-Fc刺激的类器官中抑制TGFBR信号传导可恢复类器官形成和Wnt调节的基因表达。TGFBR抑制剂将表达RSPO1-Fc的Apc小鼠腺瘤中的凋亡恢复到与注射对照载体的小鼠腺瘤相同的水平。
Apc小鼠中RSPO1的表达增加腺瘤细胞中的凋亡,减少增殖和Wnt信号传导,导致形成更少、更小的肠道肿瘤和延长小鼠存活时间。向源自腺瘤的类器官中添加RSPO1会抑制其生长并促进保留APC蛋白的肠道干细胞增殖;这些作用可被TGFB抑制剂逆转。或许可以开发增加RSPO1表达的策略来治疗肠道腺瘤。